★ America V2AuditLine ALPHA

AuditLine › HHS OIG › Centers for Medicare and Medicaid Services

HHS OIG recommendation 24-E-02-005.01

CMS should educate enrollees and providers about options for access to overdose-reversal medications, as Narcan and its generic equivalents will no…

Open UnimplementedThe publisher's status, as reported by HHS Office of Inspector General in the file read . Open for 2.9 years since it was issued.

The recommendation, in the publisher's words

CMS should educate enrollees and providers about options for access to overdose-reversal medications, as Narcan and its generic equivalents will no longer be covered by Part D.
Responsible agency
Centers for Medicare and Medicaid Services
Issued
December 11, 2023
Report
The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern (OEI-02-23-00250) · find it at HHS OIG
Kind of report
Evaluation
Agency response
Concur (as recorded by the publisher)
Last update received
September 16, 2026
Next update expected
October 5, 2027 (publisher's date)
Publisher topics
Managed Care, Mental Health, Prescription Drug, Public Health Issues, Quality of Care, Substance Abuse Disorder

“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.

Dated history

  1. Issued by HHS OIG. (publisher's date)
  2. First recorded by AuditLine. (start of AuditLine's own history for this record)

Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.

Source

Open this report in HHS OIG's tracker This publisher's records (CSV)

Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows, SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.